Manage drug-induced dry mouth with drug regimen changes, lifestyle interventions and topical or oral symptom-relieving products
- 2 Downloads
Drug-induced dry mouth (i.e. xerostomia and hyposalivation) has negative effects on general and oral health, as well as on health-related quality of life, and can lead to potentially serious complications. Options for treatment include changing the regimen of the causative drug, lifestyle interventions (e.g. increasing fluid intake and improving dental care), topical symptom-relieving products (e.g. oral moisturizers, salivary substitutes and salivary stimulators) and/or oral drugs with cholinergic salivation-stimulating properties (e.g. cevimeline and pilocarpine).
Compliance with ethical standards
Conflict of interest
The article was adapted from Drugs & Aging; 2018;35(10):877-85 by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.
The preparation of this review was not supported by any external funding.
- 6.Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72(9):841–6.Google Scholar
- 13.Thomson WM, Chalmers JM, Spencer AJ, et al. The Xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999;16(1):12–7.Google Scholar
- 18.Furness S, Worthington HV, Bryan G, et al. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011;12:104.Google Scholar
- 24.Cevimeline hydrochloride 30 mg capsules: US prescribing information. Cranbury (NJ): Sun Pharmaceuticl Industries, Inc.; 2018.Google Scholar
- 25.Committee for Proprietary Medicinal Products. Meeting report 24 to 25 April 2001. London: European Agency for the Evaluation of Medicinal Products; 2001.Google Scholar
- 26.Pilocarpine hydrochloride 5 and 7.5 mg film-coated tablets: US prescribing information. Amityville (NY): Amici Pharmaceuticals. 2018.Google Scholar
- 30.Salagen® (pilocarpine hydrochloride) 5 mg film-coated tablets: EU prescribing information. Amsterdam: Norgine B.V.; 2017.Google Scholar